StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)

Close on Nov 18, 2026Market cap $593.30MP/E –Yield –

Sight Sciences cash

Cash and short-term investments held at the end of each period.

Sight Sciences's cash was $79.75M at Jun 30, 2026. For fiscal 2025 it was $91.97M, down 23.6% from the year before. The highest annual figure on record is $260.69M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$91.97M-23.6%
FY2024Dec 31, 2024$120.36M-12.9%
FY2023Dec 31, 2023$138.13M-25.3%
FY2022Dec 31, 2022$185.00M-29.0%
FY2021Dec 31, 2021$260.69M+323.8%
FY2020Dec 31, 2020$61.51M+189.6%
FY2019Dec 31, 2019$21.24M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$79.75M-21.4%
Q1 FY2026Mar 31, 2026$84.96M-21.9%
Q4 FY2025Dec 31, 2025$91.97M-23.6%
Q3 FY2025Sep 30, 2025$92.37M-22.1%
Q2 FY2025Jun 30, 2025$101.50M-14.1%
Q1 FY2025Mar 31, 2025$108.77M-14.5%
Q4 FY2024Dec 31, 2024$120.36M-12.9%
Q3 FY2024Sep 30, 2024$118.56M-17.9%
Q2 FY2024Jun 30, 2024$118.18M-23.5%
Q1 FY2024Mar 31, 2024$127.28M-23.9%
Q4 FY2023Dec 31, 2023$138.13M-25.3%
Q3 FY2023Sep 30, 2023$144.50M-27.7%
Q2 FY2023Jun 30, 2023$154.52M-29.8%
Q1 FY2023Mar 31, 2023$167.34M-29.9%
Q4 FY2022Dec 31, 2022$185.00M-29.0%
Q3 FY2022Sep 30, 2022$199.82M-26.4%
Q2 FY2022Jun 30, 2022$220.10M+518.7%
Q1 FY2022Mar 31, 2022$238.59M+393.7%
Q4 FY2021Dec 31, 2021$260.69M+323.8%
Q3 FY2021Sep 30, 2021$271.48M+911.3%
Q2 FY2021Jun 30, 2021$35.57M-0.5%
Q1 FY2021Mar 31, 2021$48.33M+127.6%
Q4 FY2020Dec 31, 2020$61.51M–
Q3 FY2020Sep 30, 2020$26.84M–
Q2 FY2020Jun 30, 2020$35.75M–
Q4 FY2019Dec 31, 2019$21.24M–

More Sight Sciences figures

See a number that looks wrong?